CD133 is an indicator of cells that initiate tumors in numerous cancers [24, 25]; moreover, tumor cells that express CD133 demonstrate cancer stem cell properties, characterized by self-renewal capabilities in culture, in order to differentiate into cells recapitulating initial breast cancer tumors and develop tumors in animal models [26]. The gene discussed is PROM1; the disease is breast carcinoma.